Condition
Tuberculosis Infection, Latent
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Not Yet Recruiting2
Recruiting2
Enrolling By Invitation1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06498414Phase 2RecruitingPrimary
Shorter and Safer Treatment Regimens for Latent TB
NCT07472348Not Yet Recruiting
Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors
NCT06728930Enrolling By Invitation
Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
NCT07419568Not ApplicableNot Yet Recruiting
Burden of Tuberculosis Among Pregnant and Postpartum Women in Guinea-Bissau
NCT07086820Not ApplicableRecruiting
Window Prophylaxis for Pediatric Tuberculosis Prevention Trial
Showing all 5 trials